Academic Journal
Q2International Journal of Tuberculosis and Lung Disease
About International Journal of Tuberculosis and Lung Disease
About International Journal of Tuberculosis and Lung Disease
International Journal of Tuberculosis and Lung Disease is a peer-reviewed scholarly journal published by 3042 (France). It focuses on Q2. Publication coverage spans 1997-2026.
Key indicators: ISSN 1815-7920, 1027-3719; H-index 127.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (127): Exceptionally high — 127 articles have each been cited at least 127 times. This indicates deep, sustained influence in the field.
Publishing in International Journal of Tuberculosis and Lung Disease
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q2. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of International Journal of Tuberculosis and Lung Disease?
1815-7920, 1027-3719.
Who publishes International Journal of Tuberculosis and Lung Disease?
3042.
What are International Journal of Tuberculosis and Lung Disease's metrics?
H-index 127.
Is International Journal of Tuberculosis and Lung Disease peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Tuberculosis Research and Epidemiology; Diagnosis and treatment of tuberculosis; Infectious Diseases and Tuberculosis; Pneumocystis jirovecii pneumonia detection and treatment; Mycobacterium research and diagnosis; Pneumonia and Respiratory Infections.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Perception, intention and attempts to quit smoking among Jordanian adolescents from the Irbid Longitudinal Study
R. Jaber, Z. B. Taleb, R. Bahelah, P. Madhivanan et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0367Reviewer index
2016-12-01 · DOI: 10.5588/1027-3719-20.12.1700Therapeutic drug monitoring of first-line anti-tuberculosis drugs comprises more than C<SUB>2h</SUB> measurements
Marieke G. G. Sturkenboom, Mathieu S. Bolhuis, Onno W. Akkerman, Wiel C. M. de Lange et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0550Stephen Lawn, 1966–2016
Anthony D. Harries, Linda-Gail Bekker
2016-12-01 · DOI: 10.5588/ijtld.16.0744Utility of the QuantiFERON<SUP>®</SUP>-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children
S. El Azbaoui, A. Sabri, S. Ouraini, A. Hassani et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0382Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period
R. J. Bright-Thomas, A. R. Gondker, J. Morris, L. P. Ormerod et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0370Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis
B. Velayutham, D. Nair, T. Kannan, C. Padmapriyadarsini et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0096Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis
A. Singanayagam, K. Manalan, D. W. Connell, J. D. Chalmers et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0159IFN-γ promoter polymorphisms do not affect QuantiFERON<SUP>®</SUP> TB Gold In-Tube test results in a Canadian population
S. Kiazyk, L. Larcombe, C. Lopez, S. Matyas et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0223The effect of household poverty on tuberculosis
A. Siroka, I. Law, J. Macinko, K. Floyd et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0386Health care provider perspectives on tuberculosis care for foreign-born populations in New York City
J. R. Zelnick, M. R. O'Donnell, S. D. Ahuja, A. Chua et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0299Tuberculosis clinical units improve contact tracing
S. Brugueras, À. Orcau, J-P. Millet, L. Espinosa et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0147Impact of contact investigation and tuberculosis screening among high-risk groups in Denmark
S. G. Jensen, T. Lillebaek, T. Wilcke, M. K. Pedersen et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0318The contributions of Steve Lawn to the science, advocacy and policy of HIV-associated TB
Annelies Van Rie, Ted Cohen
2016-12-01 · DOI: 10.5588/ijtld.16.0771Seasonality of tuberculosis in Israel, 2001–2011
I. Margalit, C. Block, Z. Mor
2016-12-01 · DOI: 10.5588/ijtld.16.0306Implication of vitamin D-associated factors in patients with non-tuberculous mycobacterial lung disease
S-Y. Kim, B. Chang, B-H. Jeong, H. Y. Park et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0347Policies and practices on the programmatic management of latent tuberculous infection: global survey
Y. Hamada, A. Sidibe, A. Matteelli, A. Dadu et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0241Active tuberculosis patients have high levels of IgA anti-alpha-crystallin and isocitrate lyase proteins
M. Talavera-Paulín, L. García-Morales, B. P. Ruíz-Sánchez, Á. D. Caamal-Ley et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0250Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India
E. Conners, R. S. Garfein, T. C. Rodwell, Z. F. Udwadia et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0187In reply 1
Lorena Mota, Khalid Al-Efraij, Jonathon Campbell, Victoria Cook et al.
2016-12-01 · DOI: 10.5588/ijtld.16.0550-2Reviews
Community Reviews
Version History
October 9, 2026 at 9:41 pm
October 2, 2026